APA (7th ed.) Citation

D'Angelo, S. P., Lebbé, C., Mortier, L., Brohl, A. S., Fazio, N., Grob, J. -., . . . Nghiem, P. (2024). First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study. ESMO open, 9(5), . https://doi.org/10.1016/j.esmoop.2024.103461

Chicago Style (17th ed.) Citation

D'Angelo, Sandra P., et al. "First-line Avelumab Treatment in Patients with Metastatic Merkel Cell Carcinoma: 4-year Follow-up from Part B of the JAVELIN Merkel 200 Study." ESMO Open 9, no. 5 (2024). https://doi.org/10.1016/j.esmoop.2024.103461.

MLA (9th ed.) Citation

D'Angelo, Sandra P., et al. "First-line Avelumab Treatment in Patients with Metastatic Merkel Cell Carcinoma: 4-year Follow-up from Part B of the JAVELIN Merkel 200 Study." ESMO Open, vol. 9, no. 5, 2024, https://doi.org/10.1016/j.esmoop.2024.103461.